Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€240.10

€240.10

0.020%
-1.05
0.020%
€250.00

€250.00

 
Latest predictions
-
28.11.20
buy
€250.00
12.11.20
buy
-
11.08.20
€200.00
14.12.19
buy
-
23.11.19
buy
€162.36
12.01.19
buy
Your prediction

Veeva Systems A Stock

With only a change of -€1.050 (0.020%) the Veeva Systems A price is nearly unchanged from yesterday.
Our community is currently high on Veeva Systems A with 5 Buy predictions and 1 Sell predictions.
With a target price of €250.00 there is a slightly positive potential of 4.123% for Veeva Systems A compared to the current price of €240.10.
So far the community has only identified positive things for Veeva Systems A stock. The most positive votes were given for criterium "Customer and product portfolio".

Pros and Cons of Veeva Systems A in the next few years

Pros
1
Differentiated customer and product portfolio
1
Medium risks for its business
1
Could be worthwhile Investment >10% per year
Cons
0
-

Performance of Veeva Systems A vs. its peers

Security Change (%) 1w 1m 1y YTD 3y 5y
Veeva Systems A 0.020% 4.687% 2.651% 82.378% 6.498% 408.686% -
Waters Corp. -0.880% -0.885% 9.804% 3.704% 10.891% 30.233% 91.764%
Cerner Corp. -0.150% 1.983% 4.928% -0.977% 4.387% 21.564% 26.485%
Varian Medical Systems Inc. -1.380% 0.000% 0.694% 7.407% 1.399% 39.423% 172.096%

Comments

Buy Veeva Systems A

Sell Veeva Systems A

Other discussions about Veeva Systems A Stock

Trading Veeva Systems A

Trading Veeva Systems A

New thread Forum

News

Veeva Becomes First Public Company to Convert to a Public Benefit Corporation: https://mms.businesswire.com/media/20191104005259/en/747666/5/Veeva_Logo.jpg
Veeva Becomes First Public Company to Convert to a Public Benefit Corporation


Veeva Systems (NYSE: VEEV) announced that in an overwhelming majority vote, 99% of voting shareholders support the company’s proposal to become a public benefit corporation (PBC), including the

CORRECTING and REPLACING Veeva Becomes First Public Company to Convert to a Public Benefit Corporation


Please replace the release with the following corrected version due to multiple revisions.



The updated release reads:



VEEVA BECOMES FIRST PUBLIC COMPANY TO CONVERT TO A PUBLIC BENEFIT

Integra LifeSciences Selects Veeva Vault CDMS for Clinical Data Management: https://mms.businesswire.com/media/20191104005259/en/747666/5/Veeva_Logo.jpg
Integra LifeSciences Selects Veeva Vault CDMS for Clinical Data Management


Veeva Systems (NYSE: VEEV) today announced that Integra LifeSciences, a global leader in regenerative technologies, neurosurgical, and extremity orthopedic solutions, has selected Veeva Vault CDMS

Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management: https://mms.businesswire.com/media/20191104005259/en/747666/5/Veeva_Logo.jpg
Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management


Veeva Systems (NYSE: VEEV) today announced that Samsung Biologics, an award-winning global contract development and manufacturing organization (CDMO), has adopted Veeva Vault QMS to streamline

Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management: https://mms.businesswire.com/media/20191104005259/en/747666/5/Veeva_Logo.jpg
Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management


Veeva Systems (NYSE: VEEV) today announced that Samsung Biologics, an award-winning global contract development and manufacturing organization (CDMO), has adopted Veeva Vault QMS to streamline

Simbec-Orion Streamlines Trial Execution with Veeva Clinical Applications: https://mms.businesswire.com/media/20191104005259/en/747666/5/Veeva_Logo.jpg
Simbec-Orion Streamlines Trial Execution with Veeva Clinical Applications


Veeva Systems (NYSE: VEEV) today announced that Simbec-Orion, a full-service contract research organization (CRO) specialized in clinical pharmacology, oncology, and rare diseases, is adopting

Simbec-Orion Streamlines Trial Execution With Veeva Clinical Applications: https://mms.businesswire.com/media/20191104005259/en/747666/5/Veeva_Logo.jpg
Simbec-Orion Streamlines Trial Execution With Veeva Clinical Applications


Veeva Systems (NYSE: VEEV) today announced that Simbec-Orion, a full-service contract research organization (CRO) specialized in clinical pharmacology, oncology, and rare diseases, is adopting

Veeva Announces Fiscal 2021 Third Quarter Results: https://mms.businesswire.com/media/20191104005259/en/747666/5/Veeva_Logo.jpg
Veeva Announces Fiscal 2021 Third Quarter Results


Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fiscal third quarter ended October 31, 2020.

Veeva Link Expands to 11 New Therapeutic Areas: https://mms.businesswire.com/media/20191104005259/en/747666/5/Veeva_Logo.jpg
Veeva Link Expands to 11 New Therapeutic Areas


Veeva Systems (NYSE: VEEV) today announced Veeva Link for 11 new therapeutic areas, including bacterial infections, cardiology, dermatology, endocrinology, gastroenterology, hepatology, nephrology

Veeva Vault PromoMats to Support Bristol Myers Squibb in Speeding Compliant Content to Market: https://mms.businesswire.com/media/20191104005259/en/747666/5/Veeva_Logo.jpg
Veeva Vault PromoMats to Support Bristol Myers Squibb in Speeding Compliant Content to Market


Veeva Systems (NYSE: VEEV) today announced that Bristol Myers Squibb (NYSE: BMY) is adopting Veeva Vault PromoMats to deliver fast, compliant content across all digital channels to meet their

Veeva Link Expands to 11 New Therapeutic Areas: https://mms.businesswire.com/media/20191104005259/en/747666/5/Veeva_Logo.jpg
Veeva Link Expands to 11 New Therapeutic Areas


Veeva Systems (NYSE: VEEV) today announced Veeva Link for 11 new therapeutic areas, including bacterial infections, cardiology, dermatology, endocrinology, gastroenterology, hepatology, nephrology

Veeva Vault PromoMats to Support Bristol Myers Squibb in Speeding Compliant Content to Market Engagement: https://mms.businesswire.com/media/20191104005259/en/747666/5/Veeva_Logo.jpg
Veeva Vault PromoMats to Support Bristol Myers Squibb in Speeding Compliant Content to Market Engagement


Veeva Systems (NYSE: VEEV) today announced that Bristol Myers Squibb (NYSE: BMY) is adopting Veeva Vault PromoMats to deliver fast, compliant content across all digital channels to meet their

More Than 75 Companies Adopt Veeva Vault CTMS to Accelerate Clinical Research: https://mms.businesswire.com/media/20191104005259/en/747666/5/Veeva_Logo.jpg
More Than 75 Companies Adopt Veeva Vault CTMS to Accelerate Clinical Research


As the need to improve efficiency and speed in trials grows, more than 75 organizations, including six of the top 20 pharmaceutical companies, are unifying clinical information and processes with

European Survey Shows Quality Customer Reference Data Critical to Digital Engagement: https://mms.businesswire.com/media/20191104005259/en/747666/5/Veeva_Logo.jpg
European Survey Shows Quality Customer Reference Data Critical to Digital Engagement


According to new research from Veeva Systems (NYSE: VEEV), customer data is critical to digital transformation initiatives for European life sciences companies. Findings from the Veeva 2020

North America Survey Reveals Better Customer Data Essential to Digital Transformation : https://mms.businesswire.com/media/20191104005259/en/747666/5/Veeva_Logo.jpg
North America Survey Reveals Better Customer Data Essential to Digital Transformation


Access to quality customer reference data is more important than ever as the life sciences industry shifts to digital engagement, according to new research from Veeva Systems (NYSE: VEEV). Findings

Axsome Therapeutics and Veeva Systems Partner to Build Axsome’s Digital-Centric Commercialization™ Platform: https://mms.businesswire.com/media/20191104005259/en/747666/5/Veeva_Logo.jpg
Axsome Therapeutics and Veeva Systems Partner to Build Axsome’s Digital-Centric Commercialization™ Platform


Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, and Veeva Systems (NYSE: VEEV), today

Axsome Therapeutics and Veeva Systems Partner to Build Axsome’s Digital-Centric Commercialization™ Platform: https://mms.businesswire.com/media/20191104005259/en/747666/5/Veeva_Logo.jpg
Axsome Therapeutics and Veeva Systems Partner to Build Axsome’s Digital-Centric Commercialization™ Platform


Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, and Veeva Systems (NYSE: VEEV), today

Digital Leaders from Almirall and Merck KGaA, Darmstadt, Germany to Keynote Veeva Summit Online, Europe: https://mms.businesswire.com/media/20191104005259/en/747666/5/Veeva_Logo.jpg
Digital Leaders from Almirall and Merck KGaA, Darmstadt, Germany to Keynote Veeva Summit Online, Europe


Veeva Systems (NYSE: VEEV) today announced that Dr. Francesca Domenech Wuttke, chief digital officer at Almirall, and Alessandro de Luca, CIO of healthcare at Merck KGaA, Darmstadt, Germany are

Bavarian Nordic Adopting Veeva CRM and Veeva Vault PromoMats for Digital Launch of New Vaccines: https://mms.businesswire.com/media/20191104005259/en/747666/5/Veeva_Logo.jpg
Bavarian Nordic Adopting Veeva CRM and Veeva Vault PromoMats for Digital Launch of New Vaccines


Veeva Systems (NYSE: VEEV) today announced that Bavarian Nordic is adopting multichannel Veeva CRM and Veeva Vault PromoMats for the digital launch of new products in the U.S. and Europe, including

Bavarian Nordic Adopting Veeva CRM and Veeva Vault PromoMats for Digital Launch of New Vaccines: https://mms.businesswire.com/media/20191104005259/en/747666/5/Veeva_Logo.jpg
Bavarian Nordic Adopting Veeva CRM and Veeva Vault PromoMats for Digital Launch of New Vaccines


Veeva Systems (NYSE: VEEV) today announced that Bavarian Nordic is adopting multichannel Veeva CRM and Veeva Vault PromoMats for the digital launch of new products in the U.S. and Europe, including

Veeva Teams with Life Sciences to Offer Industrywide Source for Key Contacts, Information, and Services from Across Companies and Brands: https://mms.businesswire.com/media/20191104005259/en/747666/5/Veeva_Logo.jpg
Veeva Teams with Life Sciences to Offer Industrywide Source for Key Contacts, Information, and Services from Across Companies and Brands


To help healthcare professionals (HCPs) get provider and patient resources faster, Veeva Systems (NYSE: VEEV), in partnership with the industry, today introduced MyVeeva for Doctors, a mobile

Veeva Teams with Life Sciences to Offer Industrywide Source for Key Contacts, Information, and Services from Across Companies and Brands: https://mms.businesswire.com/media/20191104005259/en/747666/5/Veeva_Logo.jpg
Veeva Teams with Life Sciences to Offer Industrywide Source for Key Contacts, Information, and Services from Across Companies and Brands


To help healthcare professionals (HCPs) get provider and patient resources faster, Veeva Systems (NYSE:VEEV), in partnership with the industry, today introduced MyVeeva for Doctors, a mobile

Chief Medical Officers from Boston Scientific, Illumina, Johnson & Johnson, and QIAGEN to Keynote Veeva MedTech Summit Online: https://mms.businesswire.com/media/20191104005259/en/747666/5/Veeva_Logo.jpg
Chief Medical Officers from Boston Scientific, Illumina, Johnson & Johnson, and QIAGEN to Keynote Veeva MedTech Summit Online


Veeva Systems (NYSE: VEEV) today announced the featured keynote speakers at 2020 Veeva Medical Device & Diagnostics Summit Online. Chief medical officers from Boston Scientific, Illumina, Johnson &amp

Exact Sciences Selects Veeva Vault Clinical Suite to Help Accelerate Innovation: https://mms.businesswire.com/media/20191104005259/en/747666/5/Veeva_Logo.jpg
Exact Sciences Selects Veeva Vault Clinical Suite to Help Accelerate Innovation


Veeva Systems (NYSE: VEEV) today announced that Exact Sciences, a leading provider of cancer screening and diagnostic tests, selected Veeva Vault Clinical Suite to design and run its clinical

Roche Selects Veeva Development Cloud Applications: https://mms.businesswire.com/media/20191104005259/en/747666/5/Veeva_Logo.jpg
Roche Selects Veeva Development Cloud Applications


Veeva Systems (NYSE: VEEV) today announced that Roche (SWX: ROG) has selected Veeva Development Cloud applications globally to streamline clinical, regulatory, and quality processes. The company is